Establishment and maintenance of thyroid organoids from human cancer cells
来自人类癌细胞的甲状腺类器官的建立和维护
阅读:5
作者:Valeria Pecce, Marialuisa Sponziello, Simone Bini, Giorgio Grani, Cosimo Durante, Antonella Verrienti
| 期刊: | STAR Protocols | 影响因子: | 1.300 |
| 时间: | 2022 | 起止号: | 2022 May 15;3(2):101393. |
| doi: | 10.1016/j.xpro.2022.101393 | 种属: | Human |
| 研究方向: | 肿瘤 | 疾病类型: | 甲状腺癌 |
| 细胞类型: | 肿瘤细胞 | |
Abstract
Here, we describe a protocol to generate organoids from human thyroid cancer cells. Starting from the same patient-derived cells, we establish both organoids and primary lines. The organoid medium is supplemented with conditioned medium obtained from the primary cell line. This modification enables culture of the organoid lines for up to 10 months. Even after long-term culture, the organoids retain the genetic and phenotypic characteristics of their tissue of origin.
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。